盘点:JAMA 8月第二期原始研究汇总

2018-08-31 MedSci MedSci原创

【1】首个随机对照临床试验发现,无创产前检测和羊穿等有创检测在唐氏高危孕妇流产率上无差异 doi:10.1001/jama.2018.9396 近期,JAMA上发表的一项临床试验结果显示,对唐氏综合征高危孕妇进行筛查时,先做无创检测,再视情况做有创检查,也不比直接有创检查安全,且两种检查方式导致的产妇流产风险完全相同。研究在57家医院招募唐氏初筛高危的产妇,按1:1的比例,分为直接有创

【1】首个随机对照临床试验发现,无创产前检测和羊穿等有创检测在唐氏高危孕妇流产率上无差异

doi:10.1001/jama.2018.9396


近期,JAMA上发表的一项临床试验结果显示,对唐氏综合征高危孕妇进行筛查时,先做无创检测,再视情况做有创检查,也不比直接有创检查安全,且两种检查方式导致的产妇流产风险完全相同。研究在57家医院招募唐氏初筛高危的产妇,按1:1的比例,分为直接有创检查组,和先进行无创DNA检查,结果为阳性再做有创检查的两大组。结果在2051名接受产检的高危高龄产妇中,有16例流产出现,每组8个,流产率均为0.8%。检出率上有创检查组检出的染色体异常胎儿相对更多,此外有创检查并没有导致更多的死胎、围产期死亡等其它不良事件的发生。

【2】轻中度高血压的治疗新策略

doi:10.1001/jama.2018.10359

血压控制效果不佳是一个重要的全球公共卫生问题,近日研究人员考察了低剂量三联抗高血压药物治疗对轻中度高血压患者血压的控制效果。700名成年高血压患者参与研究,入选标准为动脉压>140 mm Hg和或舒张压>90 mm Hg,对于糖尿病及慢性肾病人群入选标准为动脉压>130 mm Hg和或舒张压>80 mm Hg。患者随机接受低剂量3D疗法(替米沙坦20mg,氨氯地平2.5mg,氯噻酮12.5mg,每日1次,n=349)或常规治疗(n=351)。结果表明,对于轻中度高血压人群,低剂量三联抗高血压药物治疗对血压的控制效果优于标准单药治疗。

【3】创伤性脑损伤可增加患者的自杀风险

doi:10.1001/jama.2018.10211

目前尚不清楚创伤性脑损伤(TBI)的医疗接触与自杀风险之间有何关联。一项来自丹麦的基于登记的回顾性队列研究中,纳入了34529例35岁以上的自杀死亡的患者。结果显示,与没有创伤性脑损伤的一般人群相比,创伤性脑损伤的患者自杀风险增加,事故发生率 1.90。结果表明创伤性脑损伤可能与自杀风险增加有关。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=342105, encodeId=e340342105e1, content=嗯嗯,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Sep 01 10:13:52 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342092, encodeId=3dd33420925f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 01 10:03:41 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342049, encodeId=b12234204946, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sat Sep 01 06:24:47 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342038, encodeId=5e9c342038f3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 01 01:36:59 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 liumin1987

    嗯嗯,学习了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=342105, encodeId=e340342105e1, content=嗯嗯,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Sep 01 10:13:52 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342092, encodeId=3dd33420925f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 01 10:03:41 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342049, encodeId=b12234204946, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sat Sep 01 06:24:47 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342038, encodeId=5e9c342038f3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 01 01:36:59 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 医者仁心5538

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=342105, encodeId=e340342105e1, content=嗯嗯,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Sep 01 10:13:52 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342092, encodeId=3dd33420925f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 01 10:03:41 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342049, encodeId=b12234204946, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sat Sep 01 06:24:47 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342038, encodeId=5e9c342038f3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 01 01:36:59 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 明月清辉

    谢谢分享,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=342105, encodeId=e340342105e1, content=嗯嗯,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Sep 01 10:13:52 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342092, encodeId=3dd33420925f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 01 10:03:41 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342049, encodeId=b12234204946, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sat Sep 01 06:24:47 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342038, encodeId=5e9c342038f3, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 01 01:36:59 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0